HEADER HYDROLASE/HYDROLASE INHIBITOR 12-NOV-12 4HY2 TITLE CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-42 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 5 13, STPK13; COMPND 6 EC: 2.7.11.21; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PL-42; COMPND 10 CHAIN: D; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK, PLK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630; SOURCE 15 OTHER_DETAILS: SYNTHETIC PEPTIDE PL-42 KEYWDS POLO-BOX DOMAIN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.LEE,J.H.SONG,H.Y.KIM REVDAT 3 15-NOV-17 4HY2 1 SOURCE REMARK REVDAT 2 22-MAY-13 4HY2 1 JRNL REVDAT 1 03-APR-13 4HY2 0 JRNL AUTH R.N.MURUGAN,J.E.PARK,D.LIM,M.AHN,C.CHEONG,T.KWON,K.Y.NAM, JRNL AUTH 2 S.H.CHOI,B.Y.KIM,D.Y.YOON,M.B.YAFFE,D.Y.YU,K.S.LEE,J.K.BANG JRNL TITL DEVELOPMENT OF CYCLIC PEPTOMER INHIBITORS TARGETING THE JRNL TITL 2 POLO-BOX DOMAIN OF POLO-LIKE KINASE 1. JRNL REF BIOORG.MED.CHEM. V. 21 2623 2013 JRNL REFN ISSN 0968-0896 JRNL PMID 23498919 JRNL DOI 10.1016/J.BMC.2013.02.020 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 13187 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 646 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1243 REMARK 3 BIN R VALUE (WORKING SET) : 0.2381 REMARK 3 BIN FREE R VALUE : 0.2389 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 63 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1813 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 78 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.08100 REMARK 3 B22 (A**2) : 4.38000 REMARK 3 B33 (A**2) : -3.29900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.11600 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.590 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.522 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.329 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.434 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 50.26 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : CNS_TOPPAR:CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : CAPPING.PAR REMARK 3 PARAMETER FILE 7 : TPO.PAR REMARK 3 PARAMETER FILE 8 : CXS.PAR REMARK 3 PARAMETER FILE 9 : 1C3.PAR REMARK 3 PARAMETER FILE 10 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CNS_TOPPAR:DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : CNS_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CNS_TOPPAR:ION.TOP REMARK 3 TOPOLOGY FILE 5 : CNS_TOPPAR:CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : CAPPING.TOP REMARK 3 TOPOLOGY FILE 7 : TPO.TOP REMARK 3 TOPOLOGY FILE 8 : CXS.TOP REMARK 3 TOPOLOGY FILE 9 : 1C3.TOP REMARK 3 TOPOLOGY FILE 10 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HY2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076063. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : UGUI REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13200 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 56.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04700 REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.24900 REMARK 200 R SYM FOR SHELL (I) : 0.24900 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CAPS PH 8, 0.2M LISO4, 0.8M REMARK 280 K2HPO4 NAH2PO4, VAPOR DIFFUSION, TEMPERATURE 293K, PH 10.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.13105 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE PL-42 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: PL-42 REMARK 400 CHAIN: D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 371 REMARK 465 CYS A 372 REMARK 465 ARG A 500 REMARK 465 GLU A 501 REMARK 465 GLY A 502 REMARK 465 ASP A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 ALA A 506 REMARK 465 ARG A 507 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 391 -70.84 -43.96 REMARK 500 ARG A 396 57.39 -119.13 REMARK 500 TYR A 421 -52.36 -121.75 REMARK 500 ASP A 449 -41.39 -136.32 REMARK 500 GLU A 455 -178.54 -69.05 REMARK 500 ASP A 457 30.81 -85.63 REMARK 500 THR A 459 96.78 -47.32 REMARK 500 LEU A 463 -165.19 -176.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF PL-42 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HAB RELATED DB: PDB DBREF 4HY2 A 371 595 UNP P53350 PLK1_HUMAN 371 595 DBREF 4HY2 D 1 7 PDB 4HY2 4HY2 1 7 SEQRES 1 A 225 ASP CYS HIS LEU SER ASP MET LEU GLN GLN LEU HIS SER SEQRES 2 A 225 VAL ASN ALA SER LYS PRO SER GLU ARG GLY LEU VAL ARG SEQRES 3 A 225 GLN GLU GLU ALA GLU ASP PRO ALA CYS ILE PRO ILE PHE SEQRES 4 A 225 TRP VAL SER LYS TRP VAL ASP TYR SER ASP LYS TYR GLY SEQRES 5 A 225 LEU GLY TYR GLN LEU CYS ASP ASN SER VAL GLY VAL LEU SEQRES 6 A 225 PHE ASN ASP SER THR ARG LEU ILE LEU TYR ASN ASP GLY SEQRES 7 A 225 ASP SER LEU GLN TYR ILE GLU ARG ASP GLY THR GLU SER SEQRES 8 A 225 TYR LEU THR VAL SER SER HIS PRO ASN SER LEU MET LYS SEQRES 9 A 225 LYS ILE THR LEU LEU LYS TYR PHE ARG ASN TYR MET SER SEQRES 10 A 225 GLU HIS LEU LEU LYS ALA GLY ALA ASN ILE THR PRO ARG SEQRES 11 A 225 GLU GLY ASP GLU LEU ALA ARG LEU PRO TYR LEU ARG THR SEQRES 12 A 225 TRP PHE ARG THR ARG SER ALA ILE ILE LEU HIS LEU SER SEQRES 13 A 225 ASN GLY SER VAL GLN ILE ASN PHE PHE GLN ASP HIS THR SEQRES 14 A 225 LYS LEU ILE LEU CYS PRO LEU MET ALA ALA VAL THR TYR SEQRES 15 A 225 ILE ASP GLU LYS ARG ASP PHE ARG THR TYR ARG LEU SER SEQRES 16 A 225 LEU LEU GLU GLU TYR GLY CYS CYS LYS GLU LEU ALA SER SEQRES 17 A 225 ARG LEU ARG TYR ALA ARG THR MET VAL ASP LYS LEU LEU SEQRES 18 A 225 SER SER ARG SER SEQRES 1 D 7 1C3 LEU HIS SER TPO MET NH2 MODRES 4HY2 TPO D 5 THR PHOSPHOTHREONINE HET 1C3 D 1 20 HET TPO D 5 11 HET NH2 D 7 1 HETNAM 1C3 1-(3,4,5-TRIMETHOXYBENZYL)-L-PROLINE HETNAM TPO PHOSPHOTHREONINE HETNAM NH2 AMINO GROUP HETSYN TPO PHOSPHONOTHREONINE FORMUL 2 1C3 C15 H21 N O5 FORMUL 2 TPO C4 H10 N O6 P FORMUL 2 NH2 H2 N FORMUL 3 HOH *78(H2 O) HELIX 1 1 HIS A 373 SER A 387 1 15 HELIX 2 2 ARG A 396 GLU A 401 5 6 HELIX 3 3 ASP A 402 ILE A 406 5 5 HELIX 4 4 PRO A 469 SER A 471 5 3 HELIX 5 5 LEU A 472 LEU A 490 1 19 HELIX 6 6 LEU A 564 GLY A 571 1 8 HELIX 7 7 CYS A 573 SER A 592 1 20 SHEET 1 A 6 VAL A 411 ASP A 416 0 SHEET 2 A 6 GLY A 422 LEU A 427 -1 O GLY A 424 N VAL A 415 SHEET 3 A 6 VAL A 432 PHE A 436 -1 O GLY A 433 N TYR A 425 SHEET 4 A 6 ARG A 441 LEU A 444 -1 O LEU A 444 N VAL A 432 SHEET 5 A 6 SER A 450 ILE A 454 -1 O ILE A 454 N ARG A 441 SHEET 6 A 6 GLU A 460 THR A 464 -1 O SER A 461 N TYR A 453 SHEET 1 B 6 LEU A 511 ARG A 516 0 SHEET 2 B 6 ALA A 520 LEU A 525 -1 O ILE A 522 N PHE A 515 SHEET 3 B 6 VAL A 530 PHE A 534 -1 O GLN A 531 N LEU A 523 SHEET 4 B 6 LYS A 540 CYS A 544 -1 O LEU A 543 N VAL A 530 SHEET 5 B 6 ALA A 549 ILE A 553 -1 O THR A 551 N ILE A 542 SHEET 6 B 6 PHE A 559 ARG A 563 -1 O TYR A 562 N VAL A 550 LINK C 1C3 D 1 N LEU D 2 1555 1555 1.33 LINK C SER D 4 N TPO D 5 1555 1555 1.34 LINK C TPO D 5 N MET D 6 1555 1555 1.33 LINK C MET D 6 N NH2 D 7 1555 1555 1.33 SITE 1 AC1 17 LYS A 413 TRP A 414 VAL A 415 ASP A 416 SITE 2 AC1 17 TYR A 485 HIS A 489 LEU A 490 LEU A 491 SITE 3 AC1 17 ARG A 516 PHE A 535 HIS A 538 LYS A 540 SITE 4 AC1 17 HOH A 607 HOH D 101 HOH D 102 HOH D 103 SITE 5 AC1 17 HOH D 104 CRYST1 35.425 50.262 57.456 90.00 101.52 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028209 0.000000 0.005739 0.00000 SCALE2 0.000000 0.019897 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017760 0.00000